Lite Strategy, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Lite Strategy, Inc. (LITS) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $86.00 thousand as of 2017-03-31, per its 10-Q filed 2017-05-04.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2017-05-04
- 2017-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $86.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $172.00K.
- 2016-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $257.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2017-03-31 | $86.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $172.00K 10-Q · filed 2017-02-08 |
| 2016-09-30 | $257.00K 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |